Skip to content

Clinical observation on efficacy of Rongze Liubai Formula in the treatment of chloasma

Clinical observation on efficacy of Rongze Liubai Formula in the treatment of chloasma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001178
Enrollment
Unknown
Registered
2025-06-15
Start date
2025-06-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Melasma

Interventions

Clinical group:Take Rongze Liubai formula twice a day one packet each half an hour after meals in the morning and evening
Control group:Take tranexamic acid tablets orally 0.25g each time twice a day

Sponsors

Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of chloasma in both traditional Chinese and Western medicine; (2) Aged 18-60 years old female gender; (3) No use of any Chinese or Western medicine for treating chloasma within two months before treatment and no adoptation of any other treatment methods for chloasma; (4) Voluntarily agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women or those who have taken oral contraceptives for a long time; (2) Patients with functional disorders of important organs (such as the heart liver kidneys etc.); (3) Patients with concurrent endocrine system abnormalities and malignant tumors; (4) Patients with damaged facial skin or other skin diseases; (5) Allergy to the research drug or cannot tolerate the test method; (6) Patients who engaged in outdoor work; (7) Patients with a history of thrombosis angina pectoris or stroke in the past; (8) Other reasons why the researcher deems it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
melasma area and severity index;The total effective rate after 3 months of treatment;

Secondary

MeasureTime frame
Facial image analysis;Quality of life assessment for Chloasma;

Countries

China

Contacts

Public ContactMi Zhou

Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

vieky2866@163.com+86 136 3668 6022

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026